Highlights d Comprehensive whole-genome analysis of 50 individuals from all giraffe subspecies d Results show four separate giraffe lineages with distinct demographic histories d Luangwa giraffe should be treated as its own separate subspecies of Masai giraffe d Chromium de novo genome assembly of the critically endangered Kordofan giraffe
Inbreeding depression occurs when inbred individuals experience reduced fitness as a result of reduced genome-wide heterozygosity. The Tasmanian devil faces extinction due to a contagious cancer, devil facial tumour disease (DFTD). An insurance metapopulation was established in 2006 to ensure the survival of the species and to be used as a source population for re-wilding and genetic rescue. The emergence of DFTD and the rapid decline of wild devil populations have rendered the species at risk of inbreeding depression. We used 33 microsatellite loci to (1) reconstruct a pedigree for the insurance population and (2) estimate genome-wide heterozygosity for 200 individuals. Using heterozygosityfitness correlations, we investigated the effect of heterozygosity on six diverse fitness measures (ulna length, asymmetry, weight-at-weaning, testes volume, reproductive success and survival). Despite statistically significant evidence of variation in individual inbreeding in this population, we found no associations between inbreeding and any of our six fitness measurements. We propose that the benign environment in captivity may decrease the intensity of inbreeding depression, relative to the stressful conditions in the wild. Future work will need to measure fitness of released animals to facilitate translation of this data to the broader conservation management of the species in its native range.The Tasmanian devil (Sarcophilus harrisii), the largest extant carnivorous marsupial, faces extinction due to the emergence of a contagious cancer called Devil Facial Tumour Disease (DFTD) 1 . In 2006, Australia's largest insurance metapopulation was established under management of the Save the Tasmanian Devil Program (STDP), in collaboration with the Zoo and Aquarium Association (ZAA), to breed Tasmanian devils away from the disease for ultimate release back into the wild 2 . Preservation of the genetic diversity of the species is critical and, at its establishment, the insurance population aimed to maintain 95% of genetic diversity over 50 years. Within the Tasmanian devil insurance population (and also in many other insurance populations for other species) the relationship of the founding individuals was unknown.The insurance metapopulation was seeded by a total of 122 founders collected over four intakes from 2005 to 2008 3 . Young, dispersing juveniles were sourced and combined with the existing captive population of 112 animals, originating from 25 genetic founders 4 (for a review and map of recent and pre-existing founder provenance see ref.2). At the time of collection, the rapid spread of DFTD across the island of Tasmania resulted in devils being preferentially sourced from the north-west of Tasmania, as populations there were disease-free (see ref.3). Despite best efforts, it is possible that some of the initial founding animals were closely related (accounting for dispersal patterns of Tasmanian devils and founder collection locations 2, 3 ). As founder intakes were weighted to two specific regions (see map 2 ), and Ta...
BackgroundThe Tasmanian devil (Sarcophilus harrisii) has undergone a recent, drastic population decline due to the highly contagious devil facial tumor disease. The tumor is one of only two naturally occurring transmissible cancers and is almost inevitably fatal. In 2006 a disease-free insurance population was established to ensure that the Tasmanian devil is protected from extinction. The insurance program is dependent upon preserving as much wild genetic diversity as possible to maximize the success of subsequent reintroductions to the wild. Accurate genotypic data is vital to the success of the program to ensure that loss of genetic diversity does not occur in captivity. Until recently, microsatellite markers have been used to study devil population genetics, however as genetic diversity is low in the devil and potentially decreasing in the captive population, a more sensitive genotyping assay is required.MethodsUtilising the devil reference genome and whole genome re-sequencing data, we have identified polymorphic regions for use in a custom genotyping assay. These regions were amplified using PCR and sequenced on the Illumina MiSeq platform to refine a set a markers to genotype the Tasmanian devil insurance population.ResultsWe have developed a set of single nucleotide polymorphic (SNP) markers, assayed by amplicon sequencing, that provide a high-throughput method for monitoring genetic diversity and assessing familial relationships among devils. To date we have used a total of 267 unique SNPs within both putatively neutral and functional loci to genotype 305 individuals in the Tasmanian devil insurance population. We have used these data to assess genetic diversity in the population as well as resolve the parentage of 21 offspring.ConclusionsOur molecular data has been incorporated with studbook management practices to provide more accurate pedigree information and to inform breeding recommendations. The assay will continue to be used to monitor the genetic diversity of the insurance population of Tasmanian devils with the aim of reducing inbreeding and maximizing success of reintroductions to the wild.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-2020-4) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.